AAAAAA

   
Results: 1-17 |
Results: 17

Authors: MYETTE MS ELFORD HL CHITAMBAR CR
Citation: Ms. Myette et al., INTERACTION OF GALLIUM NITRATE WITH OTHER INHIBITORS OF RIBONUCLEOTIDE REDUCTASE - EFFECTS ON THE PROLIFERATION OF HUMAN LEUKEMIC-CELLS, Cancer letters, 129(2), 1998, pp. 199-204

Authors: HOLLAND KP ELFORD HL BRACCHI V ANNIS CG SCHUSTER SM CHAKRABARTI D
Citation: Kp. Holland et al., ANTIMALARIAL ACTIVITIES OF POLYHYDROXYPHENYL AND HYDROXAMIC ACID-DERIVATIVES, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2456-2458

Authors: FRITZERSZEKERES M NOVOTNY L ROMANOVA D GOBL R SEDLAK J VACHALKOVA A RAUKO P ELFORD HL SZEKERES T
Citation: M. Fritzerszekeres et al., ENHANCED EFFECTS OF ADRIAMYCIN BY COMBINATION WITH A NEW RIBONUCLEOTIDE REDUCTASE INHIBITOR, TRIMIDOX, IN MURINE LEUKEMIA, Life sciences (1973), 63(7), 1998, pp. 545-552

Authors: IYAMU EW ADUNYAH SE ELFORD HL FASOLD H TURNER EA
Citation: Ew. Iyamu et al., TRIMIDOX-MEDIATED MORPHOLOGICAL-CHANGES DURING ERYTHROID-DIFFERENTIATION IS ASSOCIATED WITH THE STIMULATION OF HEMOGLOBIN AND F-CELL PRODUCTION IN HUMAN K562 CELLS, Biochemical and biophysical research communications (Print), 247(3), 1998, pp. 759-764

Authors: GALLICCHIO VS MAYHEW C OLIVER O HUGHES NK PIPER J ELFORD HL
Citation: Vs. Gallicchio et al., INHIBITION OF LYMPHOMA USING RIBONUCLEOTIDE REDUCTASE INHIBITORS DIDOX OR TRIMIDOX IN THE MURINE IMMUNODEFICIENCY MAIDS MODEL - ALONE OR INCOMBINATION WITH DDI, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 126-126

Authors: SZEKERES T FRITZERSZEKERES M ELFORD HL
Citation: T. Szekeres et al., THE ENZYME RIBONUCLEOTIDE REDUCTASE - TARGET FOR ANTITUMOR AND ANTI-HIV THERAPY, Critical reviews in clinical laboratory sciences, 34(6), 1997, pp. 503-528

Authors: ROMANOVA D VACHALKOVA A SZEKERES T ELFORD HL NOVOTNY L
Citation: D. Romanova et al., THE NEW INHIBITORS OF RIBONUCLEOTIDE REDUCTASE - COMPARISON OF SOME PHYSICOCHEMICAL PROPERTIES, Journal of pharmaceutical and biomedical analysis, 15(7), 1997, pp. 951-956

Authors: RAUKO P ROMANOVA D MIADOKOVA E MACAKOVA K NOVOTNY L ELFORD HL SZEKERES T
Citation: P. Rauko et al., DNA-PROTECTIVE ACTIVITY OF NEW RIBONUCLEOTIDE REDUCTASE INHIBITORS, Anticancer research, 17(5A), 1997, pp. 3437-3440

Authors: MAYHEW C OAKLEY O PIPER J HUGHES NK PHILLIPS J BIRCH NJ ELFORD HL GALLICCHIO VS
Citation: C. Mayhew et al., EFFECTIVE USE OF RIBONUCLEOTIDE REDUCTASE INHIBITORS (DIDOX AND TRIMIDOX) ALONE OR IN COMBINATION WITH DIDANOSINE (DDI) TO SUPPRESS DISEASEPROGRESSION AND INCREASE SURVIVAL IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS), Cellular and molecular biology, 43(7), 1997, pp. 1019-1029

Authors: FRITZERSZEKERES M NOVOTNY L VACHALKOVA A FINDENIG G ELFORD HL SZEKERES T
Citation: M. Fritzerszekeres et al., IRON-BINDING-CAPACITY OF DIDOX (3,4-DIHYDROXYBENZOBYDROXAMIC ACID) AND AMIDOX (3,4-DIHYDROXYBENZAMIDOXIME) NEW INHIBITORS OF THE ENZYME RIBONUCLEOTIDE REDUCTASE, Life sciences, 61(22), 1997, pp. 2231-2237

Authors: GALLICCHIO VS MAYHEW C OAKLEY OR HUGHES NK PIPER J ELFORD HL
Citation: Vs. Gallicchio et al., ANTIRETROVIRAL ACTIVITY OF RIBONUCLEOTIDE REDUCTASE INHIBITORS DIDOX AND TRIMIDOX IN A MURINE ACQUIRED IMMUNODEFICIENCY (MAIDS) MODEL EITHER ALONE OR IN COMBINATION WITH DDI, Experimental hematology, 24(9), 1996, pp. 378-378

Authors: SZEKERES T VIELNASCHER E NOVOTNY L VACHALKOVA A FRITZER M FINDENIG G GOBL R ELFORD HL GOLDENBERG H
Citation: T. Szekeres et al., IRON-BINDING-CAPACITY OF TRIMIDOX (3,4,5-TRIHYDROXYBENZAMIDOXIME), A NEW INHIBITOR OF THE ENZYME RIBONUCLEOTIDE REDUCTASE, European journal of clinical chemistry and clinical biochemistry, 33(11), 1995, pp. 785-789

Authors: PACE BS ELFORD HL STAMATOYANNOPOULOS G
Citation: Bs. Pace et al., TRANSGENIC MOUSE MODEL OF PHARMACOLOGICAL INDUCTION OF FETAL HEMOGLOBIN - STUDIES USING A NEW RIBONUCLEOTIDE REDUCTASE INHIBITOR, DIDOX, American journal of hematology, 45(2), 1994, pp. 136-141

Authors: SZEKERES T GHAREHBAGHI K FRITZER M WOODY M SRIVASTAVA A VANTRIET B JAYARAM HN ELFORD HL
Citation: T. Szekeres et al., BIOCHEMICAL AND ANTITUMOR-ACTIVITY OF TRIMIDOX, A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 63-66

Authors: MIKHAIL EA WANG PH KHATCHIKIAN G SERRANO CV ELFORD HL ZWEIER JL
Citation: Ea. Mikhail et al., THE NADPH OXIDASE BLOCKER IMIDATE PREVENTS NEUTROPHIL-MEDIATED INJURYIN THE POSTISCHEMIC HEART, Circulation, 90(4), 1994, pp. 372-372

Authors: MIKHAIL EA WANG PH KHATCHIKIAN G SERRANO CV ELFORD HL ZWEIER JL
Citation: Ea. Mikhail et al., THE NADPH OXIDASE BLOCKER IMIDATE PREVENTS NEUTROPHIL-MEDIATED INJURYIN THE POSTISCHEMIC HEART, Circulation, 90(4), 1994, pp. 372-372

Authors: SZEKERES T FRITZER M STROBL H GHAREHBAGHI K FINDENIG G ELFORD HL LHOTKA C SCHOEN HJ JAYARAM HN
Citation: T. Szekeres et al., SYNERGISTIC GROWTH-INHIBITORY AND DIFFERENTIATING EFFECTS OF TRIMIDOXAND TIAZOFURIN IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS, Blood, 84(12), 1994, pp. 4316-4321
Risultati: 1-17 |